• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
NTI 0.00% 7.8¢

NEUROTECH INTERNATIONAL LIMITED

Neurotech International Limited is an Australia-based clinical-stage biopharmaceutical... Neurotech International Limited is an Australia-based clinical-stage biopharmaceutical development company. The Company is focused on the development and commercialization of neurological solutions focused predominately on pediatric neurological disorders. The Company conducts clinical studies to assess the neuro-protective, anti-inflammatory, and neuro-modulatory activities of its NTI/Dolce cannabis strains. It is also commercializing Mente, a home therapy to increase engagement and improve relaxation in autistic children with elevated delta-band brain activity. Its product, Mente Autism, assists with the management of children with autism spectrum disorder (ASD). Its development program NTI164 completed a Phase I/II clinical trial to treat patients with autism spectrum disorder (ASD). Mente Autism is a portable, electroencephalographic (EEG) medical device for home use in the form of a headband that uses closed-loop neurofeedback to helo-relax the minds of children with ASD. More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
NTI 14/05/24 38 8.3K
14/05/24 Last post  Bluebush Comments Created with Sketch.  38  Views Created with Sketch.  8.3K 
NTI
Chart - NTI
2 3
11/05/24 139 53K
11/05/24 Last post  Ozibobby Comments Created with Sketch.  139  Views Created with Sketch.  53K 
NTI
International Recognition
09/05/24 0 229
Metals & Mining SECTOR NEWS

Meet Sun Silver (ASX:SS1) - ASX's newest silver player based in Nevada, USA.

SS1
17 May 2024
SUN SILVER LIMITED
09/05/24 Last post  glory Comments Created with Sketch.  0  Views Created with Sketch.  229 
NTI 09/05/24 49 12K
09/05/24 Last post  $$$$$$$$ Comments Created with Sketch.  49  Views Created with Sketch.  12K 
NTI 08/05/24 0 201
08/05/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  201 
NTI 08/05/24 0 219
08/05/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  219 
NTI 06/05/24 4 1.0K
06/05/24 Last post  Guzz Comments Created with Sketch.  4  Views Created with Sketch.  1.0K 
NTI 06/05/24 4 1.3K
06/05/24 Last post  $$$$$$$$ Comments Created with Sketch.  4  Views Created with Sketch.  1.3K 

See All Discussions arrow Created with Sketch.

Timeline

Notice of Change of Auditor
08 May 18:28
 
Change of Director's Interest Notice
08 May 13:58
 
Investor Webinar on Rett Syndrome Clinical Trial Results
06 May 09:35
 
Investor Presentation
06 May 09:34
 
Rett Syndrome Phase I/II trial shows significant benefits
06 May 09:34
 
Trading Halt
03 May 09:14
 
View More arrow Created with Sketch.
(20min delay)
Last
7.8¢
Change
0.000(0.00%)
Mkt cap ! $79.35M
Open High Low Value Volume
7.8¢ 7.8¢ 7.8¢ $2.774K 35.56K

Buyers (Bids)

No. Vol. Price($)
1 65000 7.7¢
 

Sellers (Offers)

Price($) Vol. No.
7.8¢ 63269 5
View Market Depth
Last trade - 10.06am 17/05/2024 (20 minute delay) ?
Last
7.7¢
  Change
0.000 ( 1.16 %)
Open High Low Volume
7.8¢ 7.8¢ 7.7¢ 14848
Last updated 10.21am 17/05/2024 ?
NTI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.